ZBH Zimmer Biomet Holdings Inc

WARSAW, Ind., May 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at Bernstein's 37th Annual Strategic Decisions Conference on Wednesday, June 2, 2021, at 10:00 a.m. Eastern Time.

Additionally, Mr. Hanson and Mr. Upadhyay will be presenting at the Jefferies Virtual Health Care Conference on Thursday, June 3, 2021, at 10:00 a.m. Eastern Time.

Live webcasts of the presentations can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. The webcasts will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

ZBH-Con                                                                    

View original content to download multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-bernsteins-37th-annual-strategic-decisions-conference-and-the-jefferies-virtual-health-care-conference-301294472.html

SOURCE Zimmer Biomet Holdings, Inc.